image credit: Adobe Stock

Quest Diagnostics receives EUA from US FDA for monkeypox PCR test

September 8, 2022

Quest Diagnostics has received US Food and Drug Administration (FDA) emergency use authorization (EUA) for its monkeypox polymerase chain reaction (PCR) test.

The latest move follows a declaration of monkeypox as a public health emergency by the US Department of Health and Human Services.

The Quest Diagnostics Monkeypox Virus Qualitative Real-Time PCR (Quest Monkeypox PCR) is claimed to be the first test to receive EUA due to the monkeypox public health emergency.

Read More on Medical Device Network